tert-Butyl 1-mercapto-3,6,9,12-tetraoxapentadecan-15-oate

Catalog No. :
ACOYVE915
CAS No. :
564476-33-1
Molecular Formula :
C15H30O6S
Molecular Weight :
338.47

IUPAC Name:tert-butyl 1-mercapto-3,6,9,12-tetraoxapentadecan-15-oate

tert-Butyl 1-mercapto-3,6,9,12-tetraoxapentadecan-15-oate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$98.00Login to see priceIn stockInquiry
250mg95%$147.00Login to see priceIn stockInquiry
1g95%$587.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1-mercapto-3,6,9,12-tetraoxapentadecan-15-oate
IUPAC Nametert-butyl 1-mercapto-3,6,9,12-tetraoxapentadecan-15-oate
MDL No.MFCD11041133
Molecular FormulaC15H30O6S
Molecular Weight338.47
SMILESCC(C)(OC(CCOCCOCCOCCOCCS)=O)C
InChI KeyNKLWGDQDZRFINM-UHFFFAOYSA-N
Synonymt-Butyl 3-mercapto(peg4)propionate | tert-Butyl1-mercapto-3,6,9,12-tetraoxapentadecan-15-oate | Thiol-PEG4-t-butyl ester | HY-141328 | t-Butyl 15-Mercapto-4,7,10,13-tetraoxa-pentadecanoate | SCHEMBL5144409 | BP-20978 | HS-PEG4-CH2CH2COOtBu | Thio-PEG4-t-b
CAS No.564476-33-1
PubChem CID12082267

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H318
Precautionary Statement(s)
P280-P301+P312+P330-P305+P351+P338+P310

Synthetic Route by SureRoute

1. ACOYVE915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOWDI386 route compound structure diagram
    ACOWDI3861818294-26-6 In Stock
  2. Then
  3. ACOYVE915 route product structure diagram
    ACOYVE915564476-33-1 In Stock
Inquiry

2. ACOYVE915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOYVE915 route product structure diagram
    ACOYVE915564476-33-1 In Stock
Inquiry

Comments (0)